Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caenorhabditis elegans | 11 | 2024 | 280 | 3.230 |
Why?
|
| Caenorhabditis elegans Proteins | 7 | 2024 | 143 | 2.220 |
Why?
|
| Memory | 6 | 2024 | 442 | 1.480 |
Why?
|
| CLOCK Proteins | 6 | 2015 | 33 | 1.220 |
Why?
|
| RNA-Binding Proteins | 2 | 2024 | 1008 | 0.750 |
Why?
|
| Presynaptic Terminals | 1 | 2019 | 121 | 0.660 |
Why?
|
| Bipolar Disorder | 2 | 2013 | 358 | 0.660 |
Why?
|
| Neurodegenerative Diseases | 1 | 2022 | 279 | 0.640 |
Why?
|
| Memory Consolidation | 1 | 2018 | 12 | 0.620 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2018 | 52 | 0.620 |
Why?
|
| Central Nervous System | 1 | 2019 | 459 | 0.580 |
Why?
|
| Cognitive Aging | 1 | 2016 | 2 | 0.560 |
Why?
|
| Cholecystokinin | 2 | 2013 | 51 | 0.520 |
Why?
|
| Transcriptome | 2 | 2019 | 1934 | 0.440 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 328 | 0.440 |
Why?
|
| Lithium Chloride | 1 | 2013 | 29 | 0.440 |
Why?
|
| Casein Kinase Idelta | 1 | 2012 | 6 | 0.430 |
Why?
|
| Learning | 3 | 2024 | 429 | 0.370 |
Why?
|
| RNA, Messenger | 2 | 2019 | 6493 | 0.360 |
Why?
|
| Behavior, Animal | 3 | 2024 | 758 | 0.350 |
Why?
|
| Longevity | 3 | 2022 | 154 | 0.340 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 3 | 2018 | 196 | 0.340 |
Why?
|
| Gene Expression Profiling | 3 | 2019 | 5160 | 0.330 |
Why?
|
| Animals | 19 | 2024 | 62826 | 0.300 |
Why?
|
| Signal Transduction | 4 | 2018 | 12204 | 0.250 |
Why?
|
| Ventral Tegmental Area | 3 | 2015 | 53 | 0.250 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 2024 | 44 | 0.240 |
Why?
|
| Neurons | 5 | 2024 | 2462 | 0.240 |
Why?
|
| Genome-Wide Association Study | 2 | 2024 | 2083 | 0.230 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2024 | 219 | 0.210 |
Why?
|
| Genomics | 2 | 2023 | 2814 | 0.180 |
Why?
|
| Animals, Genetically Modified | 2 | 2018 | 417 | 0.170 |
Why?
|
| Valproic Acid | 1 | 2020 | 277 | 0.170 |
Why?
|
| Genome | 1 | 2023 | 683 | 0.160 |
Why?
|
| 3' Untranslated Regions | 1 | 2019 | 337 | 0.160 |
Why?
|
| Gene Expression Regulation | 4 | 2019 | 4180 | 0.150 |
Why?
|
| Mammals | 1 | 2019 | 374 | 0.150 |
Why?
|
| Synapses | 2 | 2019 | 556 | 0.150 |
Why?
|
| Mutation | 6 | 2017 | 15828 | 0.150 |
Why?
|
| DNA Copy Number Variations | 1 | 2024 | 1542 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 2 | 2016 | 1575 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 1158 | 0.140 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2017 | 39 | 0.140 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 829 | 0.140 |
Why?
|
| Insulin | 3 | 2017 | 1509 | 0.130 |
Why?
|
| Circadian Rhythm | 2 | 2015 | 327 | 0.130 |
Why?
|
| Somatomedins | 1 | 2015 | 74 | 0.130 |
Why?
|
| Protein Biosynthesis | 1 | 2019 | 1036 | 0.130 |
Why?
|
| Binding Sites | 1 | 2019 | 2305 | 0.130 |
Why?
|
| Receptors, Dopamine D3 | 1 | 2014 | 8 | 0.120 |
Why?
|
| Dopaminergic Neurons | 1 | 2015 | 54 | 0.120 |
Why?
|
| Memory, Long-Term | 1 | 2015 | 42 | 0.120 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2014 | 46 | 0.120 |
Why?
|
| Nucleus Accumbens | 1 | 2014 | 63 | 0.120 |
Why?
|
| Corpus Striatum | 2 | 2012 | 107 | 0.110 |
Why?
|
| Models, Animal | 1 | 2016 | 675 | 0.110 |
Why?
|
| Reward | 1 | 2014 | 172 | 0.110 |
Why?
|
| Affect | 1 | 2015 | 303 | 0.110 |
Why?
|
| Protein Binding | 1 | 2019 | 3534 | 0.110 |
Why?
|
| Cocaine | 1 | 2014 | 245 | 0.100 |
Why?
|
| Receptors, Dopamine | 1 | 2012 | 52 | 0.100 |
Why?
|
| RNA | 1 | 2017 | 1067 | 0.100 |
Why?
|
| Action Potentials | 1 | 2015 | 597 | 0.100 |
Why?
|
| Ethanol | 1 | 2013 | 270 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 774 | 0.090 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2013 | 205 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 2 | 2013 | 2473 | 0.090 |
Why?
|
| Aging | 2 | 2016 | 1576 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 631 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1084 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2010 | 134 | 0.090 |
Why?
|
| Alcohol Drinking | 1 | 2013 | 592 | 0.090 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 462 | 0.090 |
Why?
|
| Mice | 7 | 2020 | 35975 | 0.080 |
Why?
|
| Hippocampus | 1 | 2015 | 976 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 1526 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2015 | 7209 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 3541 | 0.070 |
Why?
|
| Mice, Transgenic | 4 | 2015 | 4368 | 0.060 |
Why?
|
| Phenotype | 1 | 2015 | 6454 | 0.060 |
Why?
|
| Dopamine Agents | 2 | 2015 | 36 | 0.060 |
Why?
|
| Systems Biology | 1 | 2024 | 115 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 3243 | 0.050 |
Why?
|
| Histone Deacetylase 2 | 1 | 2020 | 36 | 0.050 |
Why?
|
| Humans | 5 | 2024 | 270836 | 0.050 |
Why?
|
| Motor Activity | 2 | 2015 | 718 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 7457 | 0.040 |
Why?
|
| Male | 5 | 2015 | 128405 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2017 | 112 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 627 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2017 | 309 | 0.030 |
Why?
|
| Adaptation, Ocular | 1 | 2015 | 17 | 0.030 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2015 | 87 | 0.030 |
Why?
|
| Swimming | 1 | 2015 | 29 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2015 | 88 | 0.030 |
Why?
|
| Maze Learning | 1 | 2015 | 140 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 431 | 0.030 |
Why?
|
| Food Preferences | 1 | 2015 | 123 | 0.030 |
Why?
|
| Space Perception | 1 | 2014 | 74 | 0.030 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 649 | 0.030 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2014 | 91 | 0.030 |
Why?
|
| Cell Separation | 1 | 2015 | 616 | 0.030 |
Why?
|
| Rats | 2 | 2015 | 6659 | 0.030 |
Why?
|
| Regeneration | 1 | 2015 | 282 | 0.030 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2012 | 11 | 0.030 |
Why?
|
| Homovanillic Acid | 1 | 2012 | 27 | 0.030 |
Why?
|
| Colforsin | 1 | 2012 | 70 | 0.030 |
Why?
|
| Axons | 1 | 2015 | 443 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 665 | 0.020 |
Why?
|
| Choice Behavior | 1 | 2013 | 206 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 5436 | 0.020 |
Why?
|
| Sex Characteristics | 1 | 2013 | 429 | 0.020 |
Why?
|
| Dopamine | 1 | 2012 | 342 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2010 | 54 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 1757 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 594 | 0.020 |
Why?
|
| Time Factors | 2 | 2015 | 13122 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 917 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 2316 | 0.020 |
Why?
|
| Plasmids | 1 | 2010 | 952 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2010 | 1882 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 5113 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2010 | 2465 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 3496 | 0.010 |
Why?
|
| Gene Expression | 1 | 2010 | 3681 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2015 | 5489 | 0.010 |
Why?
|
| Female | 1 | 2013 | 148425 | 0.000 |
Why?
|